U.S. Communications Stock News

NasdaqGS:CENT
NasdaqGS:CENTHousehold Products

A Look At Central Garden & Pet (NasdaqGS:CENT) Valuation As Recent Share Price Momentum Cools

Why Central Garden & Pet is on investors’ radar Central Garden & Pet (CENT) has attracted attention after recent share price moves, with the stock up about 3% over the past month but down roughly 2% over the past 3 months. See our latest analysis for Central Garden & Pet. At a share price of $38.48, Central Garden & Pet has a year to date share price return of 20.44%. Its 1 year total shareholder return of 6.71% and 3 year total shareholder return of 29.45% point to momentum that has cooled...
NYSE:H
NYSE:HHospitality

Hyatt Hotels (H) Valuation Check As Shares Trade Near Fair Value After Strong Recent Momentum

Recent trading snapshot and performance context Hyatt Hotels (H) has been moving on solid recent trading activity, with the stock closing at US$181.36 and posting gains over the past week, month, past 3 months and year. See our latest analysis for Hyatt Hotels. While the share price slipped 2.21% on the latest trading day, the recent 30-day share price return of 14.13% and 1-year total shareholder return of 37.88% indicate that positive momentum has been building rather than fading. If strong...
NYSE:NGL
NYSE:NGLOil and Gas

NGL Energy Partners (NGL) Q4 Loss Deepens And Challenges Forecasted Profitability Turnaround Narrative

NGL Energy Partners (NGL) just posted its FY 2026 numbers with fourth quarter revenue of US$2.4 billion and a basic EPS loss of US$1.31 per share, setting a clear tone for how the year wrapped up. Over recent quarters, the company has seen revenue move from US$971.1 million in Q4 FY 2025 to US$2.4 billion in Q4 FY 2026. Quarterly EPS has swung between a loss of US$0.26 in Q1 FY 2026 and a small profit of US$0.10 in Q3 before sliding back into a wider loss in Q4, leaving margins under pressure...
NasdaqGS:TTWO
NasdaqGS:TTWOEntertainment

Take Two Q1 Margins Highlight Direct To Consumer And GTA VI Focus

Take-Two Interactive Software (NasdaqGS:TTWO) reported strong Q1 results with margin improvements tied to its direct-to-consumer strategy. Management highlighted the role of direct customer relationships in supporting profitability alongside key franchises. Analysts focused on future GTA VI pricing, mobile growth, NBA 2K engagement, and the use of AI in advertising on the company’s earnings call. For investors tracking NasdaqGS:TTWO, this update goes beyond headline game launches and...
NYSE:CLVT
NYSE:CLVTProfessional Services

Clarivate Launches IPOne To Deepen AI Powered IP Workflow Integration

Clarivate (NYSE:CLVT) has launched IPOne, a unified platform for intellectual property research and workflows. The platform uses AI agents combined with Clarivate's proprietary data to support corporate IP teams and law firms. IPOne is positioned to support real-world legal and business use cases across the IP management process. Clarivate, known for data and analytics across science, patents, and trademarks, is moving further into AI driven tools with IPOne. For investors watching legal...
NYSE:U
NYSE:USoftware

Is It Time To Reassess Unity Software (U) After Its Recent Share Price Rebound?

If you are wondering whether Unity Software's current share price reflects its true worth, the recent trading range gives you plenty to think about. Unity Software closed at US$30.47 recently, with the stock up 19.2% over the past week and 16.7% over the past month, while still down 31.1% year to date and 68.0% over five years, and showing a 16.8% gain over the last year and a 1.7% decline over three years. Recent headlines around Unity Software have largely focused on ongoing investor...
NYSE:CALX
NYSE:CALXCommunications

Assessing Calix (CALX) Valuation After Nex-Tech Partnership Expansion And AI Platform Updates

Calix (CALX) is back in focus after Nex-Tech said it will expand a 21 year partnership and adopt Calix Agent Workforce Cloud on the AI native Calix One platform across residential, business, and MDU markets. See our latest analysis for Calix. Even with recent product launches and the expanded Nex-Tech agreement highlighting interest in its AI native platform, Calix’s share price has slipped over the year. The 90 day share price return is down 23.22% and the 1 year total shareholder return is...
NYSE:SNA
NYSE:SNAMachinery

Snap-on Beat And Optimism Reinforce Long-Term Earnings Support Narrative

Snap-on (NYSE:SNA) reported stronger than expected quarterly results in its latest update. Management highlighted improving tools activity and steady demand across key end markets. The company paired the results with an optimistic outlook on business momentum. For investors watching NYSE:SNA, the update comes with the stock recently around $371.21 and solid multi year returns, including 18.9% over the past year and 54.7% over three years. Over five years, the stock is up 66.3%, which helps...
NYSE:NAT
NYSE:NATOil and Gas

Nordic American Tankers (NAT) One Off Gain Fuels 16.3% Margin And Tests Bullish Narratives

Nordic American Tankers (NAT) has opened 2026 with Q1 revenue of US$79.3 million and basic EPS of US$0.22, setting the tone for how its earnings profile looks against a trailing twelve month backdrop of US$333.8 million in revenue and EPS of US$0.26. Over recent quarters the company has seen revenue move from US$37.9 million in Q1 2025 to US$168.6 million in Q4 2025 and then to US$79.3 million in Q1 2026, while quarterly EPS shifted from US$0.02 to US$0.06 and then US$0.22 across the same...
NYSE:VZ
NYSE:VZTelecom

A Look At Verizon (VZ) Valuation As Views Diverge On Overvaluation Versus DCF Upside

Recent performance snapshot for Verizon Communications (VZ) Verizon Communications (VZ) has drawn investor attention after a mixed stretch in its share price, with the stock up over the past month but down over the past 3 months and week. See our latest analysis for Verizon Communications. With the share price at $47.81, Verizon shows a 30 day share price return of 2.57%, while year to date share price gains of 17.99% and a 3 year total shareholder return of 69.21% point to momentum that has...
NYSE:PFS
NYSE:PFSBanks

A Look At Provident Financial Services (PFS) Valuation After Recent Share Price Momentum

Why Provident Financial Services Is On Investors’ Radar Provident Financial Services (PFS) is drawing investor attention after recent share price moves, with the stock posting mixed short term returns while still showing stronger performance over the past year and past 3 months. See our latest analysis for Provident Financial Services. The recent move to a US$22.19 share price comes after a modest 7 day share price return of 0.63% and a 30 day period that slipped slightly, set against a...
NYSE:ETR
NYSE:ETRElectric Utilities

Is It Too Late To Consider Entergy (ETR) After A 34% One-Year Rally?

If you are wondering whether Entergy stock still offers value after a strong run, this article walks through what the current price might be implying. Entergy closed at US$109.05, with the stock down 3.0% over the past week and 4.9% over the past month, while still showing a 16.2% return year to date and a 34.3% return over the past year. These moves sit against a backdrop where Entergy continues to feature in broader discussions about regulated utilities, grid reliability and long term...
NYSE:AMP
NYSE:AMPCapital Markets

Will Record EPS And Growing AUM Change Ameriprise Financial's (AMP) Long‑Term Strength Narrative?

In the past quarter, Ameriprise Financial reported record adjusted EPS and highlighted solid business momentum, including growth in assets under management and pretax earnings. This combination of record profitability and expanding client assets has supported a more constructive analyst view of Ameriprise’s long‑term business strength. With record adjusted EPS underscoring operational momentum, we’ll now examine how this earnings performance reshapes Ameriprise Financial’s investment...
NYSE:BBAI
NYSE:BBAIIT

BigBear.ai Panama Deal Tests AI Cargo Security Beyond Defense Roots

BigBear.ai Holdings (NYSE:BBAI) has entered a commercial agreement with Panama's largest logistics operator, PTG, to deploy a co-developed International Shipping Compliance application. The new AI-powered platform focuses on international cargo security, with features such as biometric verification, chain-of-custody tracking, and real-time risk intelligence. The rollout is designed to support regulatory compliance and reduce manual workloads for customs officials involved in cross-border...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Why Tempus AI (TEM) Is Up 9.3% After New FDA CDx Approval And AI Platform Upgrades

In late May 2026, Tempus AI received FDA approval for a tumor-only indication for its 648-gene xT CDx companion diagnostic, while also rolling out major AI upgrades across its Next and Hub platforms and launching the ArteraAI Prostate Test within its ecosystem. This combination of regulatory clearance and expanded AI-enabled decision support underscores Tempus AI’s push to make precision oncology testing more accessible, integrated, and clinically actionable across multiple tumor...
NasdaqGS:CINF
NasdaqGS:CINFInsurance

Cincinnati Financial’s Rising Costs Put Profit Margins Under Closer Scrutiny

Cincinnati Financial, ticker NasdaqGS:CINF, is drawing attention as rising expenses have outpaced revenue, pressuring pre-tax profit margins. Recent updates point to profitability slowing compared with insurance peers, raising fresh questions about the company’s near term competitiveness. These developments follow a period when discussion around the stock focused more on valuation and share price than on its underlying cost trends. Cincinnati Financial’s latest operational trends are...
NYSE:BMY
NYSE:BMYPharmaceuticals

Bristol Myers Squibb’s Mezigdomide Data Reframes Multiple Myeloma Pipeline Story

Bristol Myers Squibb (NYSE:BMY) reported landmark positive Phase 3 SUCCESSOR-2 results for mezigdomide in relapsed or refractory multiple myeloma. The late breaking data, presented at ASCO 2026, showed a statistically and clinically significant improvement in progression free survival. The study used mezigdomide, a next generation CELMoD, in combination with standard therapy for patients with limited treatment options. The news around mezigdomide comes as Bristol Myers Squibb trades at...
NYSE:KD
NYSE:KDIT

Is Kyndryl Holdings (KD) Offering Opportunity After A 68% Twelve Month Share Price Fall

This article examines whether Kyndryl Holdings at around US$12.47 is a bargain or a value trap, and explores what the current price might be implying. The stock has risen 1.5% over the past week, but is down 10.8% over the past month, 51.1% year to date and 68.1% over the last 12 months. These moves may have changed how investors view both its potential and its risks. Recent coverage has focused on Kyndryl as a standalone IT services specialist following its spin out from IBM, with attention...
NasdaqGS:LI
NasdaqGS:LIAuto

Assessing Li Auto (NasdaqGS:LI) Valuation After New Model Launch Margin Pressures And Share Buybacks

Li Auto (NasdaqGS:LI) is back in focus after a busy week that combined operational updates, capital returns and governance changes, giving investors fresh information on the company’s direction and current risk profile. See our latest analysis for Li Auto. Despite the busy week of earnings, guidance and governance updates, Li Auto’s share price has been under pressure, with a 1-month share price return of 15.44% down and a 1-year total shareholder return of 47.04% down. This suggests that...
NYSE:AJG
NYSE:AJGInsurance

Is Arthur J. Gallagher (AJG) Now Attractive After A 41% One Year Share Price Fall?

If you are wondering whether Arthur J. Gallagher is starting to look better value after a weak share price patch, this article walks through what the current price might be implying about the stock. The stock last closed at US$201.11, with the share price down 1.8% over the past week, down 5.1% over the past month, and down 21.4% year to date, contributing to a 41.5% decline over the past year and a 45.8% gain over five years. These moves sit against a backdrop of ongoing interest in large...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Strength And Long Term Gains

Amneal Pharmaceuticals (AMRX) is back in focus after recent trading that left the stock with a 1 day gain of 1.7% and a 7 day move of 6.0%, prompting fresh attention from investors. See our latest analysis for Amneal Pharmaceuticals. Zooming out, the recent 6.0% 7 day share price return comes after a modest 30 day gain of 2.9% and a 90 day share price decline of 4.6%. However, the 1 year total shareholder return of 79.9% and 3 year total shareholder return of more than 4x suggest momentum has...
NasdaqGS:EQIX
NasdaqGS:EQIXSpecialized REITs

Equinix Geo Zones Targets Data Sovereignty As Stock Trades Below Targets

Equinix launched Equinix Fabric Geo Zones, a global multi-cloud data sovereignty solution designed to enforce geographic boundaries at the network level. The new capability is aimed at helping customers address tightening data regulations such as GDPR in Europe and LGPD in Brazil. Equinix Fabric Geo Zones focus on secure, compliant cloud connectivity for workloads that cross regional and national borders. For investors watching NasdaqGS:EQIX, this product launch comes with the stock trading...
NasdaqGS:RKLB
NasdaqGS:RKLBAerospace & Defense

Rocket Lab Wins Key US$816m SDA Role As Valuation Risk Grows

Rocket Lab passed the System Requirements Review for the Space Development Agency's Tracking Layer Tranche 3 missile tracking constellation. The review confirms its technical solution meets the program's needs and sets Rocket Lab's approach as the baseline for the project. This positions Rocket Lab as prime contractor on an $816m U.S. national security space contract that is still in early program stages. For investors watching NasdaqGS:RKLB, this milestone follows a very strong share price...
NYSE:GCO
NYSE:GCOSpecialty Retail

Genesco (GCO) Returns To Trailing Profitability But Q1 Loss Rekindles Earnings Volatility Debate

Genesco (GCO) opened fiscal Q1 2027 with revenue of US$487.0 million and a basic EPS loss of US$1.42, while trailing 12 month revenue stood at US$2.4 billion with basic EPS of US$1.90. Over recent periods, quarterly revenue has moved between US$474.0 million and US$799.9 million, and quarterly EPS has ranged from a loss of US$2.02 to a profit of US$4.60, giving investors a wide set of outcomes to weigh against the latest print. With the share price around US$38.37, a key question now is how...